To all that replied to my inquiry and thoughts, thank you. I gain a great amount of knowledge and deeper understanding of CYDY and Leronlimab from many of you. All have made valid points which I agree with and genuinely appreciate the honest feedback, i.e. we all seem to agree and see the need for the funds with the shares offering. If we will actually need to cash any of them in at all, is a matter of the business at hand, and to an even greater extent, business that is going on behind closed doors. Yep, that's how non-revenue biotechs (and others) typically fund operations. I don't feel like my waiting to vote is holding the company or management hostage in any way. My shares are a drop in the overall bucket. I am sure they haven't noticed my votes are still outstanding and when I do vote "for", they won't notice then either.

I was also encouraged by those responses that are looking for at least some communication to us owners. I'm not asking for an opus from the company, but providing some information on such a large ask is a reasonable request, especially as one response said, we just approved another large ask (200M) fairly recently. We may only receive the standard "to fund operations" answer, which would meet the minimum expectation. CYDY has to play the cards close to the vest and I get that. However, if management would be so inclined to reach out prior to August 31, it would be encouraging to know the status of whatever irons are in the fire that they can update us on, and specifically for the vote, I would be interested in more information on: 1. how the figure of 350M shares was decided, and 2. what is the plan of use, if and when, that fund raising is needed? These are reasonable questions. In my experience working with BODs, there is precise planning that goes into decisions such as these and though the communication piece is purposefully bare-bones, it is important to provide that communication piece to the stakeholders.